{
    "id": 26674,
    "fullName": "SQSTM1 - NTRK2",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SQSTM1-NTRK2 results from the fusion of SQSTM1 and NTRK2, which leads to increased Erk phosphorylation and is transforming in cultured cells (PMID: 28512244). SQSTM1-NTRK2 has been identified in low grade gliomas (PMID: 28512244).",
            "references": [
                {
                    "id": 9257,
                    "pubMedId": 28512244,
                    "title": "Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28512244"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 8878,
        "geneSymbol": "SQSTM1",
        "terms": [
            "SQSTM1",
            "A170",
            "DMRV",
            "FTDALS3",
            "NADGP",
            "OSIL",
            "p60",
            "p62",
            "p62B",
            "PDB3",
            "ZIP3"
        ]
    },
    "variant": "SQSTM1 - NTRK2",
    "createDate": "07/03/2017",
    "updateDate": "10/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 4915,
                "geneSymbol": "NTRK2",
                "terms": [
                    "NTRK2",
                    "EIEE58",
                    "GP145-TrkB",
                    "OBHD",
                    "trk-B",
                    "TRKB"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 11365,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing SQSTM1-NTRK2 demonstrated sensitivity to Rozlytrek (entrectinib) in culture (PMID: 28512244).",
            "molecularProfile": {
                "id": 27969,
                "profileName": "SQSTM1 - NTRK2"
            },
            "therapy": {
                "id": 1455,
                "therapyName": "Entrectinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9257,
                    "pubMedId": 28512244,
                    "title": "Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28512244"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27969,
            "profileName": "SQSTM1 - NTRK2",
            "profileTreatmentApproaches": [
                {
                    "id": 19325,
                    "name": "Larotrectinib",
                    "profileName": "SQSTM1 - NTRK2"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}